ONCOReveal Lung & Colon Cancer Panel

The ONCOReveal Lung and Colon Cancer Panel is a targeted assay for relevant hotspot mutations in both lung and colon cancer types. This ONCOReveal panel targets 1,800 total hotspots across 22 genes.*

Benefits:

  • Requires as little as 2.5ng of input DNA
  • Compatible with genomic DNA , FFPE, and cfDNA
  • Single sample / single well assay technology for enhanced sensitivity
  • 100% Coverage uniformity within .15x of the mean
  • Detect down to 1% allele frequency
Lung and Colon Target Genes (22 in total)
AKT1 ALK BRAF CTNNB1 DDR2 EGFR ERBB2 ERBB4 FBXW7 FGFR1 TP53
FGFR2 FGFR3 KRAS MAP2K1 MET NOTCH1 NRAS PIK3CA PTEN SMAD4 STK11
 

*Targets are based on data across consortia and organizations such as the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), the National Comprehensive Cancer Network (NCCN), and Catalog Of Somatic Mutations In Cancer (COSMIC) database, in addition to ongoing clinical trials.